<DOC>
	<DOCNO>NCT01033942</DOCNO>
	<brief_summary>This exploratory mixed-methods research study compare efficacious behavioral HIV-prevention intervention ( 3MV ) alone behavioral HIV-prevention intervention combine biomedical intervention ( PrEP ) . After complete 3MV behavioral intervention , participant randomly assign one three study arm : 1 ) daily FTC/TDF PrEP , 2 ) placebo pill control , 3 ) `` pill '' control . Behavioral biomedical data collect baseline every 4 week thereafter 24 week . Youth decline participate ask complete brief survey opinion PrEP . Qualitative interview complete six study participant study coordinator end trial explore issue trial acceptability feasibility . Finally , focus group conduct explore feasibility acceptability issue YMSM meet eligibility requirement study except age 18 old , least 16 year age .</brief_summary>
	<brief_title>Pre-Exposure Prophylaxis YMSM</brief_title>
	<detailed_description />
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Willing able independently provide write informed consent ; Of male gender birth ; Between age 18 year 0 day 22 year 364 day time sign informed consent ; Selfreporting least one episode unprotected anal intercourse male within last 12 month time Personal Digital Assistant ( PDA ) Screening Interview ; Tests HIV negative time screen ( use FDAapproved HIV diagnostic test ) ; Willing provide locator information study staff ; Willing assign three biomedical intervention condition ; Does report intention relocate study area course study ; Does job/other obligation would require long absence area ( &gt; 4 week time ) . Transgender ( behavioral intervention target toward population ) ; Presence serious psychiatric symptom ( e.g. , active hallucination ) ; Visibly distraught time consent ( e.g. , suicidal , homicidal , exhibit violent behavior ) ; Intoxicated influence alcohol drug time consent ; Acute chronic hepatitis B infection ( exclude hepatitis B surface antigen positive ) ; Renal dysfunction ( Creatinine Clearance &lt; 75 ml/min ) ; Use CockcroftGault equation : Glomerular Filtration Rate ( GFR ) = ( 140Age year ) x ( Weight kg ) / ( 72 x serum creatinine ) males Any history bone fracture explain trauma ; Confirmed proteinuria ( repeat positive [ &gt; 2+ ] urine dipstick ) , unless explain orthostatic proteinuria ; Confirmed glucosuria ( repeat positive [ &gt; 1+ ] urine dipstick ) presence normal blood glucose ( &lt; 120 mg/dL ) ; Any Grade 3 toxicity screening tests/assessments ; Concurrent participation HIV vaccine study investigational drug study ; Known allergy/sensitivity study drug component . Use disallow medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pre-exposure prophylaxis</keyword>
	<keyword>HIV Prevention</keyword>
	<keyword>Truvada</keyword>
	<keyword>Many Men , Many Voices</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Tenofovir disoproxil fumarate</keyword>
	<keyword>Young men sex men</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>